| User's Publication |
|
20513
Kono M, Komatsuda H, Yamaki H, Kumai T, Hayashi R, Wakisaka R, Nagato T, Ohkuri T, Kosaka A, Ohara K, Kishibe K, Takahara M, Katada A, Hayashi T, Kobayashi H, Harabuchi Y.
Immunomodulation via FGFR inhibition augments FGFR1 targeting T-cell based antitumor immunotherapy for head and neck squamous cell carcinoma.
Oncoimmunology
2022
11(1):2021619
PubMed ID: 35003900
|
|
20559
Komatsu M, Saito K, Miyamoto I, Koike K, Iyoda M, Nakashima D, Kasamatsu A, Shiiba M, Tanzawa H, Uzawa K.
Aberrant GIMAP2 expression affects oral squamous cell carcinoma progression by promoting cell cycle and inhibiting apoptosis.
Oncol Lett
2022
23(2):49
PubMed ID: 34992682
|
|
20085
Kase Y, Uzawa K, Wagai S, Yoshimura S, Yamamoto JI, Toeda Y, Okubo M, Eizuka K, Ando T, Nobuchi T, Kawasaki K, Saito T, Iyoda M, Nakashima D, Kasamatsu A, Tanzawa H.
Engineered exosomes delivering specific tumor-suppressive RNAi attenuate oral cancer progression.
Sci Rep
2021
11(1):5897
PubMed ID: 33723306
|
|
14341
Kono M, Kumai T, Hayashi R, Yamaki H, Komatsuda H, Wakisaka R, Nagato T, Ohkuri T, Kosaka A, Ohara K, Kishibe K, Takahara M, Katada A, Hayashi T, Celis E, Kobayashi H, Harabuchi Y.
Interruption of MDM2 signaling augments MDM2-targeted T cell-based antitumor immunotherapy through antigen-presenting machinery
Cancer Immunol Immunother
2021
PubMed ID: 33866408
|
|
20509
Tanaka N, Minemura C, Asai S, Kikkawa N, Kinoshita T, Oshima S, Koma A, Kasamatsu A, Hanazawa T, Uzawa K, Seki N.
Identification of miR-199-5p and miR-199-3p Target Genes: Paxillin Facilities Cancer Cell Aggressiveness in Head and Neck Squamous Cell Carcinoma.
Genes (Basel)
2021
12(12)
PubMed ID: 34946859
|
|
16138
Ando T, Kasamatsu A, Kawasaki K, Hiroshima K, Fukushima R, Iyoda M, Nakashima D, Endo-Sakamoto Y, Uzawa K.
Tumor Suppressive Circular RNA-102450: Development of a Novel Diagnostic Procedure for Lymph Node Metastasis from Oral Cancer
Cancers (Basel)
2021
13(22):5708
PubMed ID: 34830863
|
|
16139
Kase-Kato I, Asai S, Minemura C, Tsuneizumi K, Oshima S, Koma A, Kasamatsu A, Hanazawa T, Uzawa K, Seki N.
Molecular Pathogenesis of the Coronin Family: CORO2A Facilitates Migration and Invasion Abilities in Oral Squamous Cell Carcinoma
Int J Mol Sci
2021
22(23):12684
PubMed ID: 34884487
|
|
16206
Koma A, Asai S, Minemura C, Oshima S, Kinoshita T, Kikkawa N, Koshizuka K, Moriya S, Kasamatsu A, Hanazawa T, Uzawa K, Seki N.
Impact of Oncogenic Targets by Tumor-Suppressive miR-139-5p and miR-139-3p Regulation in Head and Neck Squamous Cell Carcinoma
Int J Mol Sci
2021
22(18):9947
PubMed ID: 34576110
|
|
12061
Ohara M, Ohara K, Kumai T, Ohkuri T, Nagato T, Hirata-Nozaki Y, Kosaka A, Nagata M, Hayashi R, Harabuchi S, Yajima Y, Oikawa K, Harabuchi Y, Sumi Y, Furukawa H, Kobayashi H.
Phosphorylated vimentin as an immunotherapeutic target against metastatic colorectal cancer.
Cancer Immunol. Immunother.
2020
PubMed ID: 32086539
|
|
12083
Hashimura S, Kido J, Matsuda R, Yokota M, Matsui H, Inoue-Fujiwara M, Inagaki Y, Hidaka M, Tanaka T, Tsutsumi T, Nagata T, Tokumura A.
A low level of lysophosphatidic acid in human gingival crevicular fluid from patients with periodontitis due to high soluble lysophospholipase activity: Its potential protective role on alveolar bone loss by periodontitis.
Biochim Biophys Acta Mol Cell Biol Lipids
2020
PubMed ID: 32179099
|
|
13172
Li XH, Li D, Liu C, Zhang MM, Guan XJ, Fu YP.
p33ING1b regulates acetylation of p53 in oral squamous cell carcinoma via SIR2.
Cancer Cell Int
2020
PubMed ID: 32831651
|
|
13401
Hayashi R, Nagato T, Kumai T, Ohara K, Ohara M, Ohkuri T, Hirata-Nozaki Y, Harabuchi S, Kosaka A, Nagata M, Yajima Y, Yasuda S, Oikawa K, Kono M, Kishibe K, Takahara M, Katada A, Hayashi T, Celis E, Harabuchi Y, Kobayashi H.
Expression of placenta-specific 1 and its potential for eliciting anti-tumor helper T-cell responses in head and neck squamous cell carcinoma.
Oncoimmunology
2020
PubMed ID: 33457076
|
|
13903
Aika Tanzawa et al.
Comprehensive gene expression analysis of semaphorins in oral squamous cell carcinoma
Oral Science International
2020
17(2):67-72
|
|
11354
Nakamura Y, Nakahata S, Kondo Y, Izumi A, Yamamoto K, Ichikawa T, Tamura T, Noumi K, Yamashita Y, Morishita K.
Overexpression of absent in melanoma 2 in oral squamous cell carcinoma contributes to tumor progression.
Biochem. Biophys. Res. Commun.
2019
PubMed ID: 30587341
|
|
11405
Uzawa K, Kasamatsu A, Saito T, Kita A, Sawai Y, Toeda Y, Koike K, Nakashima D, Endo Y, Shiiba M, Takiguchi Y, Tanzawa H.
Growth suppression of human oral cancer cells by candidate agents for cetuximab-side effects.
Exp. Cell Res.
2019
PubMed ID: 30690028
|
|
11497
Yasukochi A, Kawakubo-Yasukochi T, Morioka M, Hazekawa M, Nishinakagawa T, Ono K, Nakashima M, Nakamura S.
Regulation of collagen type XVII expression by miR203a-3p in oral squamous cell carcinoma cells.
J. Biochem.
2019
PubMed ID: 30918974
|
|
11759
Uzawa K, Amelio AL, Kasamatsu A, Saito T, Kita A, Fukamachi M, Sawai Y, Toeda Y, Eizuka K, Hayashi F, Kato-Kase I, Sunohara M, Iyoda M, Koike K, Nakashima D, Ogawara K, Endo-Sakamoto Y, Shiiba M, Takiguchi Y, Yamauchi M, Tanzawa H.
Resveratrol Targets Urokinase-Type Plasminogen Activator Receptor Expression to Overcome Cetuximab-Resistance in Oral Squamous Cell Carcinoma.
Sci Rep
2019
PubMed ID: 31434965
|
|
9696
Kazuya Hiroshima, Masashi Shiiba, Noritoshi Oka, Fumihiko Hayashi, Sho Ishida, Reo Fukushima, Kazuyuki Koike, Manabu Iyoda, Dai Nakashima, Hideki Tanzawa, Katsuhiro Uzawa
Tspan15 Plays a Crucial Role in Metastasis in Oral Squamous Cell Carcinoma
Exp Cell Res
2019
384(2):111622
PubMed ID: 31518558
|
|
11907
Cervino G, Fiorillo L, Herford AS, Romeo U, Bianchi A, Crimi S, D'Amico C, De Stefano R, Troiano G, Santoro R, Laino L, Laino G, Cicciù M.
Molecular Biomarkers Related to Oral Carcinoma: Clinical Trial Outcome Evaluation in a Literature Review.
Dis. Markers
2019
PubMed ID: 31019584
|
|
12366
Zhang C, Qiao H, Guo W, Liu Y, Yang L, Liu Y, Jin B, Fu M, Wang G, Li W.
CD100-plexin-B1 induces epithelial-mesenchymal transition of head and neck squamous cell carcinoma and promotes metastasis
Cancer Lett
2019
455:1-13
PubMed ID: 30981760
|
|
12457
Eizuka K, Nakashima D, Oka N, Wagai S, Takahara T, Saito T, Koike K, Kasamatsu A, Shiiba M, Tanzawa H, Uzawa K.
SYT12 plays a critical role in oral cancer and may be a novel therapeutic target
J Cancer
2019
10(20):4913-4920
PubMed ID: 31598163
|
|
12586
Sato K, Shi L, Ito F, Ohara Y, Motooka Y, Tanaka H, Mizuno M, Hori M, Hirayama T, Hibi H, Toyokuni S.
Non-thermal plasma specifically kills oral squamous cell carcinoma cells in a catalytic Fe(II)-dependent manner
J Clin Biochem Nutr
2019
65(1):8-15
PubMed ID: 31379408
|
|
10682
Yamamoto JI, Kasamatsu A, Okubo Y, Nakashima D, Fushimi K, Minakawa Y, Kasama H, Shiiba M, Tanzawa H, Uzawa K.
Evaluation of tryptophan-aspartic acid repeat-containing protein 34 as a novel tumor-suppressor molecule in human oral cancer.
Biochem. Biophys. Res. Commun.
2018
495:2469-2474
PubMed ID: 29278705
|
|
10806
Okubo Y, Kasamatsu A, Yamatoji M, Fushimi K, Ishigami T, Shimizu T, Kasama H, Shiiba M, Tanzawa H, Uzawa K.
Diacylglycerol lipase alpha promotes tumorigenesis in oral cancer by cell-cycle progression.
Exp. Cell Res.
2018
367:112-118
PubMed ID: 29614312
|
|
11226
Fukushima R, Kasamatsu A, Nakashima D, Higo M, Fushimi K, Kasama H, Endo-Sakamoto Y, Shiiba M, Tanzawa H, Uzawa K.
Overexpression of Translocation Associated Membrane Protein 2 Leading to Cancer-Associated Matrix Metalloproteinase Activation as a Putative Metastatic Factor for Human Oral Cancer.
J Cancer
2018
PubMed ID: 30271493
|
|
4183
Ohara K, Ohkuri T, Kumai T, Nagato T, Nozaki Y, Ishibashi K, Kosaka A, Nagata M, Harabuchi S, Ohara M, Oikawa K, Aoki N, Harabuchi Y, Celis E, Kobayashi H.
Targeting phosphorylated p53 to elicit tumor-reactive T helper responses against head and neck squamous cell carcinoma.
Oncoimmunology
2018
PubMed ID: 30510853
|
|
16201
Sawai Y, Kasamatsu A, Nakashima D, Fushimi K, Kasama H, Iyoda M, Kouzu Y, Shiiba M, Tanzawa H, Uzawa K.
Critical role of deoxynucleotidyl transferase terminal interacting protein 1 in oral cancer
Lab Invest
2018
98(8):980-988
PubMed ID: 29855544
|
|
10148
Takahara T, Kasamatsu A, Yamatoji M, Iyoda M, Kasama H, Saito T, Takeuchi S, Endo-Sakamoto Y, Shiiba M, Tanzawa H, Uzawa K.
SIPA1 promotes invasion and migration in human oral squamous cell carcinoma by ITGB1 and MMP7.
Exp. Cell Res.
2017
352:357-363
PubMed ID: 28237246
|
|
10155
Koide N, Kasamatsu A, Endo-Sakamoto Y, Ishida S, Shimizu T, Kimura Y, Miyamoto I, Yoshimura S, Shiiba M, Tanzawa H, Uzawa K.
Evidence for Critical Role of Lymphocyte Cytosolic Protein 1 in Oral Cancer.
Sci Rep
2017
7:43379
PubMed ID: 28230172
|
|
10191
Takeuchi S, Kasamatsu A, Yamatoji M, Nakashima D, Endo-Sakamoto Y, Koide N, Takahara T, Shimizu T, Iyoda M, Ogawara K, Shiiba M, Tanzawa H, Uzawa K.
TEAD4-YAP interaction regulates tumoral growth by controlling cell-cycle arrest at the G1 phase.
Biochem. Biophys. Res. Commun.
2017
486:385-390
PubMed ID: 28315328
|
|
10418
Kita A, Kasamatsu A, Nakashima D, Endo-Sakamoto Y, Ishida S, Shimizu T, Kimura Y, Miyamoto I, Yoshimura S, Shiiba M, Tanzawa H, Uzawa K.
Activin B Regulates Adhesion, Invasiveness, and Migratory Activities in Oral Cancer: a Potential Biomarker for Metastasis.
J Cancer
2017
8:2033-2041
PubMed ID: 28819404
|
|
10958
Inactivation of dermatopontin via histone deacetylation in human oral cancer
Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology
2017
29, 400-404
|
|
11036
Increased Expression of CD44v9, A Cancer Stem Cell Marker, in Head And Neck Squamous Cell Carcinoma Cells after Irradiation
Int J Cancer Oncol
2017
4: 225- 230
|
|
6029
Ishida S et al
Novel mechanism of aberrant ZIP4 expression with zinc supplementation in oral tumorigenesis.
Biochem Biophys Res Commun
2017
483(1):339-345
PubMed ID: 28017725
|
|
12679
Tamura T, Ichikawa T, Nakahata S, Kondo Y, Tagawa Y, Yamamoto K, Nagai K, Baba T, Yamaguchi R, Futakuchi M, Yamashita Y, Morishita K.
Loss of NDRG2 Expression Confers Oral Squamous Cell Carcinoma with Enhanced Metastatic Potential
Cancer Res
2017
77(9):2363-2374
PubMed ID: 28209617
|
|
14229
Shiiba M, Yamagami H, Yamamoto A, Minakawa Y, Okamoto A, Kasamatsu A, Sakamoto Y, Uzawa K, Takiguchi Y, Tanzawa H.
Mefenamic acid enhances anticancer drug sensitivity via inhibition of aldo-keto reductase 1C enzyme activity
Oncol Rep
2017
37(4):2025-2032
PubMed ID: 28259989
|
|
14306
Noriko Komatsu, Kenichi Mitsui, Osamu Kusano-Arai, Hiroko Iwanari, Kazuto Hoshi, Tsuyoshi Takato, Takahiro Abe and Takao Hamakubo
Enhancement of anti-robo1 immunotoxin cytotoxicity to head and neck squamous cell carcinoma via photochemical internalization
Archives in Cancer Research
2017
5
|
|
9616
Kitajima D, Kasamatsu A, Nakashima D, Miyamoto I, Kimura Y, Saito T, Suzuki T, Endo-Sakamoto Y, Shiiba M, Tanzawa H, Uzawa K.
Tie2 Regulates Tumor Metastasis of Oral Squamous Cell Carcinomas.
J Cancer
2016
7:600-7
PubMed ID: 27053959
|
|
9630
Kimura Y, Kasamatsu A, Nakashima D, Yamatoji M, Minakawa Y, Koike K, Fushimi K, Higo M, Endo-Sakamoto Y, Shiiba M, Tanzawa H, Uzawa K.
ARNT2 Regulates Tumoral Growth in Oral Squamous Cell Carcinoma.
J Cancer
2016
7:702-10
PubMed ID: 27076852
|
|
6036
Suzuki T, Kasamatsu A, Miyamoto I, Saito T, Higo M, Endo-Sakamoto Y, Shiiba M, Tanzawa H, Uzawa K.
Overexpression of TMOD1 is associated with enhanced regional lymph node metastasis in human oral cancer.
Int J Oncol.
2016
48(2):607-12
PubMed ID: 26718916
|
|
6044
Kasama H et al
Adenosine A2b receptor promotes progression of human oral cancer.
BMC Cancer
2015
15:563
PubMed ID: 26228921
|
|
6051
Okamoto A et al
Down-Regulation of Nucleolar and Spindle-Associated Protein 1 (NUSAP1) Expression Suppresses Tumor and Cell Proliferation and Enhances Anti-Tumor Effect of Paclitaxel in Oral Squamous Cell Carcinoma.
PLoS One
2015
10(11):e0142252
PubMed ID: 26554377
|
|
6052
Saito T et al
Semaphorin7A Promotion of Tumoral Growth and Metastasis in Human Oral Cancer by Regulation of G1 Cell Cycle and Matrix Metalloproteases: Possible Contribution to Tumoral Angiogenesis.
PLoS One
2015
10(9):e0137923
PubMed ID: 26378920
|
|
6054
Baba T et al
Persephin: A potential key component in human oral cancer progression through the RET receptor tyrosine kinase-mitogen-activated protein kinase signaling pathway.
Mol Carcinog
2015
54(8):608-17
PubMed ID: 24375483
|
|
6058
Shida-Sakazume T et al
Lysophosphatidylcholine acyltransferase1 overexpression promotes oral squamous cell carcinoma progression via enhanced biosynthesis of platelet-activating factor.
PLoS One.
2015
10(3):e0120143
PubMed ID: 25803864
|
|
15042
Koyama T, Ogawara K, Kasamatsu A, Okamoto A, Kasama H, Minakawa Y, Shimada K, Yokoe H, Shiiba M, Tanzawa H, Uzawa K.
ANGPTL3 is a novel biomarker as it activates ERK/MAPK pathway in oral cancer
Cancer Med
2015
4(5):759-69
PubMed ID: 25644496
|
|
15186
Kumai T, Matsuda Y, Ohkuri T, Oikawa K, Ishibashi K, Aoki N, Kimura S, Harabuchi Y, Celis E, Kobayashi H.
c-Met is a novel tumor associated antigen for T-cell based immunotherapy against NK/T cell lymphoma
Oncoimmunology
2015
4(2):e976077
PubMed ID: 25949874
|
|
5778
Ishige S, Kasamatsu A, Ogoshi K, Saito Y, Usukura K, Yokoe H, Kouzu Y, Koike H, Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H, Uzawa K.
Decreased expression of kallikrein-related peptidase 13: possible contribution to metastasis of human oral cancer.
Mol Carcinog
2014
53(7):557-65
PubMed ID: 23371469
|
|
5307
Kumai T, Oikawa K, Aoki N, Kimura S, Harabuchi Y, Celis E, Kobayashi H.
Tumor-derived TGF-β and prostaglandin E2 attenuate anti-tumor immune responses in head and neck squamous cell carcinoma treated with EGFR inhibitor.
J Transl Med
2014
12:265
PubMed ID: 25240937
|
|
16010
Fukumoto C, Nakashima D, Kasamatsu A, Unozawa M, Shida-Sakazume T, Higo M, Ogawara K, Yokoe H, Shiiba M, Tanzawa H, Uzawa K.
WWP2 is overexpressed in human oral cancer, determining tumor size and poor prognosis in patients: downregulation of WWP2 inhibits the AKT signaling and tumor growth in mice
Oncoscience
2014
1(12):807-20
PubMed ID: 25621296
|
|
5432
Taiyoji M, Yamanaka T, Tsuno T, Ohtsubo S.
Potential value of a rice protein extract, containing proteinaceous inhibitors against cysteine proteinases from Porphyromonas gingivalis, for managing periodontal diseases.
Biosci Biotechnol Biochem
2013
77(1):80-6
PubMed ID: 23291749
|
|
5028
Saito Y, Kasamatsu A, Yamamoto A, Shimizu T, Yokoe H, Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H, Uzawa K.
ALY as a potential contributor to metastasis in human oral squamous cell carcinoma.
J Cancer Res Clin Oncol
2013
139(4):585-94
PubMed ID: 23242234
|
|
6067
Koike K, Kasamatsu A, Iyoda M, Saito Y, Kouzu Y, Koike H, Sakamoto Y, Ogawara K, Tanzawa H, Uzawa K.
High prevalence of epigenetic inactivation of the human four and a half LIM domains 1 gene in human oral cancer.
Int J Oncol
2013
42(1):141-50
PubMed ID: 23123766
|
|
6072
Uchida F, Uzawa K, Kasamatsu A, Takatori H, Sakamoto Y, Ogawara K, Shiiba M, Bukawa H, Tanzawa H.
Overexpression of CDCA2 in human squamous cell carcinoma: correlation with prevention of G1 phase arrest and apoptosis.
PLoS One
2013
8(2):e56381
PubMed ID: 23418564
|
|
6074
Shimizu F1, Shiiba M2, Ogawara K3, Kimura R1, Minakawa Y1, Baba T1, Yokota S, Nakashima D1, Higo M3, Kasamatsu A3, Sakamoto Y3, Tanzawa H4, Uzawa K4.
Overexpression of LIM and SH3 Protein 1 leading to accelerated G2/M phase transition contributes to enhanced tumourigenesis in oral cancer.
PLoS One
2013
8(12):e83187
PubMed ID: 24386158
|
|
6076
Minakawa Y, Kasamatsu A, Koike H, Higo M, Nakashima D, Kouzu Y, Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H, Uzawa K.
Kinesin family member 4A: a potential predictor for progression of human oral cancer.
PLoS One. 2
2013
8(12):e85951
PubMed ID: 24386490
|
|
6078
Hotta H, Hamamura K, Yamashita K, Shibuya H, Tokuda N, Hashimoto N, Furukawa K, Yamamoto N, Hattori H, Toyokuni S, Ueda M, Furukawa K.
Lewis y antigen is expressed in oral squamous cell carcinoma cell lines and tissues, but disappears in the invasive regions leading to the enhanced malignant properties irrespective of sialyl-Lewis x.
Glycoconj J
2013
30(6):585-97
PubMed ID: 23242548
|
|
6081
Kimura R, Kasamatsu A, Koyama T, Fukumoto C, Kouzu Y, Higo M, Endo-Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H, Uzawa K.
Glutamate acid decarboxylase 1 promotes metastasis of human oral cancer by β-catenin translocation and MMP7 activation.
BMC Cancer
2013
13:555
PubMed ID: 24261884
|
|
6083
Kumai T, Matsuda Y, Oikawa K, Aoki N, Kimura S, Harabuchi Y, Celis E, Kobayashi H.
EGFR inhibitors augment antitumour helper T-cell responses of HER family-specific immunotherapy.
Br J Cancer
2013
109(8):2155-66
PubMed ID: 24045666
|
|
6093
Uzawa K, Baba T, Uchida F, Yamatoji M, Kasamatsu A, Sakamoto Y, Ogawara K, Shiiba M, Bukawa H, Tanzawa H.
Circulating tumor-derived mutant mitochondrial DNA: a predictive biomarker of clinical prognosis in human squamous cell carcinoma.
Oncotarget
2012
3(7):670-7
PubMed ID: 22832574
|
|
6099
Kishimoto K, Yoshida S, Ibaragi S, Yoshioka N, Okui T, Hu GF, Sasaki A.
Hypoxia-induced up-regulation of angiogenin, besides VEGF, is related to progression of oral cancer.
Oral Oncol
2012
48(11):1120-7
PubMed ID: 22694909
|
|
6120
Furuta H, Kondo Y, Nakahata S, Hamasaki M, Sakoda S, Morishita K.
NDRG2 is a candidate tumor-suppressor for oral squamous-cell carcinoma.
Biochem Biophys Res Commun
2010
391(4):1785-91
PubMed ID: 20045673
|
|
13818
Kikuji Yamashita, Shine-Od Dalkhsuren, Tatsuo Ishikawa, Kaori Sumida, Jun Ishibashi, Hiroyoshi Hosokawa, Akemichi Ueno, Fumio Nasu, Seiichiro Kitamura
Far Infrared Ray Radiation Inhibits the Proliferation of A549, HSC3 and Sa3 Cancer Cells through Enhancing the Expression of ATF3 Gene
Journal of Electromagnetic Analysis and Applications
2010
2:382-394
|
|
6410
Danjoh I, Sone H, Noda N, Iimura E, Nagayoshi M, Saijo K, Hiroyama T, Nakamura Y.
Is parainfluenza virus a threatening virus for human cancer cell lines?
Hum Cell
2009
22(3):81-4
PubMed ID: 19624309
|
|
8843
Yasuharu Ohgoe, Kenji K. Hirakuri, Kazuhide Ozaki and Yasuhiro Fukui
Investigation of Diamond-Like Carbon Coating for Orthodontic Archwire
New Diamond and Frontier Carbon Technology
2007
17:281-288
|
|
15687
Kobayashi S, Ohgoe Y, Ozeki K, Hirakuri K, Aoki H.
Dissolution effect and cytotoxicity of diamond-like carbon coatings on orthodontic archwires
J Mater Sci Mater Med
2007
18(12):2263-8
PubMed ID: 17562139
|
|
2906
Nishimaki, Haruaki, Kasai, Kenji, Kozaki, Ken ichi, Takeo, Tomohiro, Ikeda, Hiroshi, Saga, Shinsuke, Nitta, Masakazu, Itoh, Gen
A role of activated Sonic hedgehog signaling for the cellular proliferation of oral squamous cell carcinoma cell line.
Biochem Biophys Res Commun
2004
314:313-20
PubMed ID: 14733907
|
|
6156
Nakayama S, Sasaki A, Mese H, Alcalde RE, Tsuji T, Matsumura T.
The E-cadherin gene is silenced by CpG methylation in human oral squamous cell carcinomas.
Int J Cancer.
2001
93(5):667-73
PubMed ID: 11477576
|
Back
Top
CELL BANK Website
